Fig. 1From: Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registryPublished consensus treatment plans for new onset JDM patients with moderate, skin predominant and skin resistant diseaseBack to article page